You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

~ Buy the ONEXTON (benzoyl peroxide; clindamycin phosphate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ONEXTON


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ONEXTON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02578043 ↗ A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris Completed Taro Pharmaceuticals USA Phase 1 2015-04-01 The objectives of this study are to evaluate the therapeutic equivalence and safety.
NCT02616614 ↗ Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris Completed Actavis Inc. Phase 3 2015-05-01 Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris
NCT03402893 ↗ The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color Completed Derm Research, PLLC Phase 4 2017-07-28 This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and Weeks 4, 8, and 16. All subjects will receive Onexton at Baseline and be instructed to apply the gel once daily to the face. The investigators will evaluate Investigator Global Assessment of acne (IGA), total lesion count, inflammatory lesion count, non-inflammatory lesion count, Investigator Global Assessment of Post-Inflammatory Hyperpigmentation and distribution of Post-Inflammatory Hyperpigmentation, adverse events and concomitant medications.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ONEXTON

Condition Name

Condition Name for ONEXTON
Intervention Trials
Acne Vulgaris 3
Post Inflammatory Hyperpigmentation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ONEXTON
Intervention Trials
Acne Vulgaris 3
Hyperpigmentation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ONEXTON

Trials by Country

Trials by Country for ONEXTON
Location Trials
United States 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ONEXTON
Location Trials
Ohio 1
North Carolina 1
Nebraska 1
Missouri 1
Kansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ONEXTON

Clinical Trial Phase

Clinical Trial Phase for ONEXTON
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ONEXTON
Clinical Trial Phase Trials
Completed 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ONEXTON

Sponsor Name

Sponsor Name for ONEXTON
Sponsor Trials
Taro Pharmaceuticals USA 1
Actavis Inc. 1
Derm Research, PLLC 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ONEXTON
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.